{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:42:03Z","timestamp":1787499723667,"version":"build-2736575974"},"reference-count":38,"publisher":"American Chemical Society (ACS)","issue":"7","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"name":"Tyra Biosciences, Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Chem."],"published-print":{"date-parts":[[2026,4,9]]},"DOI":"10.1021\/acs.jmedchem.6c00514","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T05:49:46Z","timestamp":1774936186000},"page":"8614-8627","source":"Crossref","is-referenced-by-count":1,"title":["Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations"],"prefix":"10.1021","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8250-7679","authenticated-orcid":true,"given":"Robert L.","family":"Hudkins","sequence":"first","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Allen","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samhita","family":"Iyer","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Balcer","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Neal","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Rideout","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb B.","family":"Frye","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1160-5251","authenticated-orcid":true,"given":"Kirk J.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2694-802X","authenticated-orcid":true,"given":"Isaac D.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline H.","family":"Starrett","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Harris","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald V.","family":"Swanson","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Bensen","sequence":"additional","affiliation":[{"name":"Tyra Biosciences, Inc., 2656 State Street, Carlsbad, California 92008, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"ref1\/cit1","doi-asserted-by":"publisher","DOI":"10.1042\/BST20180004"},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2004.08.007"},{"key":"ref3\/cit3","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2792"},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00222-7"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.3390\/cells8060614"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1002\/wdev.176"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20101603"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102170"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1200\/PO.17.00080"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-3212"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05066-5"},{"key":"ref12\/cit12","unstructured":"LYTGOBI\u00ae (futibatinib)\n                      Highlights Of\nPrescribing\nInformation\n                      , 2022. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/214801s000lbl.pdf."},{"key":"ref13\/cit13","unstructured":"PEMAZYRE\u00ae (pemigatinib)\n                      Highlights\nOf Prescribing\nInformation\n                      , 2022. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/213736s002lbl.pdf."},{"key":"ref14\/cit14","unstructured":"TRUSELTIQ\u00ae (infigratinib)\n                      Highlights Of Prescribing\nInformation\n                      , 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/214622s000lbl.pdf."},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2317756121"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0475"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c00928"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c03205"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.5c00232"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01163"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101204"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13122968"},{"key":"ref23\/cit23","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103091"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2020.08.026"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2024.11.005"},{"key":"ref26\/cit26","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00869-z"},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.11.017"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-1317"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.12.011"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2026.01.004"},{"key":"ref31\/cit31","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-02477"},{"key":"ref32\/cit32","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00446"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0b013e328011a25f"},{"key":"ref34\/cit34","first-page":"MEDI 4313617","volume-title":"First time disclosures: Breakthrough in new medicines: Presented at the ACS Fall 2025 National Meeting","author":"Hudkins R. L.","year":"2025"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.4c01531"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.116.072983"},{"key":"ref37\/cit37","unstructured":"Smith, A. L.; Brennan, P. E.; Demorin, F. F.; Liu, G.; Paras, N. A.; Retz, D. M. Aminopyrimidine compounds and methods of use; WO 2,006,066,172 A1, 2007."},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c02552"}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c00514","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c00514","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:14:37Z","timestamp":1775722477000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.6c00514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4,9]]}},"alternative-id":["10.1021\/acs.jmedchem.6c00514"],"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c00514","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]}}}